Cargando…
A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing
The CRISPR-Cas system can treat autosomal dominant diseases by nonhomologous end joining (NHEJ) gene disruption of mutant alleles. However, many single-nucleotide mutations cannot be discriminated from wild-type alleles by current CRISPR-Cas systems. Here, we functionally screened six Cas12j nucleas...
Autores principales: | Wang, Yao, Qi, Tao, Liu, Jingtong, Yang, Yuan, Wang, Ziwen, Wang, Ying, Wang, Tianyi, Li, Miaomiao, Li, Mingqing, Lu, Daru, Chang, Alex Chia Yu, Yang, Li, Gao, Song, Wang, Yongming, Lan, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917002/ https://www.ncbi.nlm.nih.gov/pubmed/36763662 http://dx.doi.org/10.1126/sciadv.abo6405 |
Ejemplares similares
-
Host nucleases generate prespacers for primed adaptation in the E. coli type I-E CRISPR-Cas system
por: Shiriaeva, Anna A., et al.
Publicado: (2022) -
A far-red light–inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation
por: Wang, Xinyi, et al.
Publicado: (2021) -
Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice
por: Bu, Wen, et al.
Publicado: (2023) -
Hierarchical self-uncloaking CRISPR-Cas13a–customized RNA nanococoons for spatial-controlled genome editing and precise cancer therapy
por: Fan, Ningke, et al.
Publicado: (2022) -
Genome-editing prodrug: Targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease
por: Yan, Xiaojie, et al.
Publicado: (2021)